Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and

Minakshi Mazumdar1, Arghya Adhikary, Samik Chakraborty

  • 1Division of Molecular Medicine, Bose Institute, P-1/12, Calcutta Improvement Trust Road, Scheme VII M, Kolkata, West Bengal, 700 054, India.

Insights

Theaflavins from black tea induce programmed cell death in medullary thyroid carcinoma (MTC) by targeting the RET pathway. This research highlights theaflavins as a potential therapeutic strategy for MTC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Medullary thyroid carcinoma (MTC) is driven by RET receptor tyrosine kinase mutations.
  • MTC exhibits poor response to conventional chemotherapy, necessitating novel therapeutic targets.
  • RET signaling is crucial for MTC cell survival and proliferation.

Purpose of the Study:

  • To investigate the anti-cancer effects of theaflavins, black tea components, on MTC.
  • To elucidate the molecular mechanisms underlying theaflavin-induced apoptosis in MTC cells.
  • To validate RET as a therapeutic target for MTC.

Main Methods:

  • Utilized human MTC cell line (TT) for in vitro studies.
  • Investigated theaflavin's impact on key signaling pathways (PI3K/Akt/Bad, p38MAPK/caspase-8/caspase-3, Ras/Raf/ERK).
  • Employed gene manipulation techniques (over-expression of Myr-Akt-cDNA, Dn-caspase-8-cDNA) to dissect apoptotic pathways.
  • Analyzed the role of lipid rafts and RET anchorage in theaflavin's mechanism of action.

Main Results:

  • Theaflavins induced apoptosis in MTC cells by modulating PI3K/Akt/Bad and p38MAPK/caspase-8/caspase-3 pathways.
  • Theaflavins caused loss of mitochondrial transmembrane potential, cytochrome-c release, and caspase activation.
  • Disruption of lipid rafts by theaflavins interfered with RET anchorage, inhibiting Ras and PI3Kinase phosphorylation.
  • Over-expression studies confirmed the involvement of Akt and caspase-8 in theaflavin-induced apoptosis.

Conclusions:

  • Theaflavins trigger programmed cell death in MTC through a novel mechanism involving RET signaling disruption.
  • Theaflavins represent a promising therapeutic agent for MTC, targeting the oncogenic RET pathway.
  • This study validates RET as a key target for developing novel MTC therapies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...